These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 20053142)

  • 1. Neurocognitive impairment and psychiatric comorbidity in well-controlled human immunodeficiency virus-infected Thais from the 2NN Cohort Study.
    Pumpradit W; Ananworanich J; Lolak S; Shikuma C; Paul R; Siangphoe U; Chaoniti N; Kaew-On P; Paris R; Ruxrungtham K; Valcour V;
    J Neurovirol; 2010 Feb; 16(1):76-82. PubMed ID: 20053142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropsychological Assessment of 412 HIV-Infected Individuals in São Paulo, Brazil.
    Gascón MRP; Vidal JE; Mazzaro YM; Smid J; Marcusso RMN; Capitão CG; Coutinho EM; Benute GRG; De Lucia MCS; de Oliveira ACP
    AIDS Patient Care STDS; 2018 Jan; 32(1):1-8. PubMed ID: 29323557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low levels of neurocognitive impairment detected in screening HIV-infected men who have sex with men: The MSM Neurocog Study.
    Barber TJ; Bansi L; Pozniak A; Asboe D; Nelson M; Moyle G; Davies N; Margetts A; Ratcliffe D; Catalan J; Boffito M; Gazzard B
    Int J STD AIDS; 2017 Jun; 28(7):715-722. PubMed ID: 27510645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psycho-behavioral factors associated with neurocognitive performance among people living with HIV on antiretroviral therapy in Accra, Ghana.
    Asiedu N; Kretchy I; Asampong E
    Afr Health Sci; 2020 Jun; 20(2):487-596. PubMed ID: 33163015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV-associated cognitive impairment before and after the advent of combination therapy.
    Sacktor N; McDermott MP; Marder K; Schifitto G; Selnes OA; McArthur JC; Stern Y; Albert S; Palumbo D; Kieburtz K; De Marcaida JA; Cohen B; Epstein L
    J Neurovirol; 2002 Apr; 8(2):136-42. PubMed ID: 11935465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and pattern of neuropsychological impairment in human immunodeficiency virus-infected/acquired immunodeficiency syndrome (HIV/AIDS) patients across pre- and post-highly active antiretroviral therapy eras: a combined study of two cohorts.
    Cysique LA; Maruff P; Brew BJ
    J Neurovirol; 2004 Dec; 10(6):350-7. PubMed ID: 15765806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening for neurocognitive impairment, depression, and anxiety in HIV-infected patients in Western Europe and Canada.
    Robertson K; Bayon C; Molina JM; McNamara P; Resch C; Muñoz-Moreno JA; Kulasegaram R; Schewe K; Burgos-Ramirez A; De Alvaro C; Cabrero E; Guion M; Norton M; van Wyk J
    AIDS Care; 2014; 26(12):1555-61. PubMed ID: 25029599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV-Associated Dementia: Associated Factors and Characteristics of Cognitive Domain Abnormalities in Elderly People Living with HIV Treated with Highly Active Antiretroviral Therapy.
    Boonyagars L; Kiatsoongsong N; Winitprichagul S
    Am J Trop Med Hyg; 2022 Dec; 107(6):1250-1257. PubMed ID: 36315995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Motor function and human immunodeficiency virus-associated cognitive impairment in a highly active antiretroviral therapy-era cohort.
    Robinson-Papp J; Byrd D; Mindt MR; Oden NL; Simpson DM; Morgello S;
    Arch Neurol; 2008 Aug; 65(8):1096-101. PubMed ID: 18695060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurocognitive impairment among HIV-positive individuals in Botswana: a pilot study.
    Lawler K; Mosepele M; Ratcliffe S; Seloilwe E; Steele K; Nthobatsang R; Steenhoff A
    J Int AIDS Soc; 2010 Apr; 13():15. PubMed ID: 20406460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The neuropsychological profile of symptomatic AIDS and ADC patients in the pre-HAART era: a meta-analysis.
    Cysique LA; Maruff P; Brew BJ
    J Int Neuropsychol Soc; 2006 May; 12(3):368-82. PubMed ID: 16903129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive disorders in HIV-infected patients: are they HIV-related?
    Bonnet F; Amieva H; Marquant F; Bernard C; Bruyand M; Dauchy FA; Mercié P; Greib C; Richert L; Neau D; Catheline G; Dehail P; Dabis F; Morlat P; Dartigues JF; Chêne G;
    AIDS; 2013 Jan; 27(3):391-400. PubMed ID: 23079813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Depression and diagnosis of neurocognitive impairment in HIV-positive patients.
    Pinheiro CA; Souza LD; Motta JV; Kelbert EF; Souza MS; Martins CS; Coelho FM; Pinheiro KA; Pinheiro RT
    Braz J Med Biol Res; 2016 Sep; 49(10):e5344. PubMed ID: 27626305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV associated neurocognitive disorders (HAND) in Malawian adults and effect on adherence to combination anti-retroviral therapy: a cross sectional study.
    Kelly CM; van Oosterhout JJ; Ngwalo C; Stewart RC; Benjamin L; Robertson KR; Khoo S; Allain TJ; Solomon T
    PLoS One; 2014; 9(6):e98962. PubMed ID: 24915530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aging, neurocognitive impairment and adherence to antiretroviral therapy in human immunodeficiency virus-infected individuals.
    Pinheiro CA; Mattos Souza LD; Motta JV; Kelbert EF; Martins CS; Souza MS; Pinheiro KA; Coelho FM; Pinheiro RT
    Braz J Infect Dis; 2016; 20(6):599-604. PubMed ID: 27789283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV-associated neurocognitive disorders (HAND).
    Elbirt D; Mahlab-Guri K; Bezalel-Rosenberg S; Gill H; Attali M; Asher I
    Isr Med Assoc J; 2015 Jan; 17(1):54-9. PubMed ID: 25739180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurocognitive functioning in pediatric human immunodeficiency virus infection: effects of combined therapy.
    Shanbhag MC; Rutstein RM; Zaoutis T; Zhao H; Chao D; Radcliffe J
    Arch Pediatr Adolesc Med; 2005 Jul; 159(7):651-6. PubMed ID: 15996999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Virologically suppressed patients with asymptomatic and symptomatic HIV-associated neurocognitive disorders do not display the same pattern of immune activation.
    Vassallo M; Durant J; Lebrun-Frenay C; Fabre R; Ticchioni M; Andersen S; DeSalvador F; Harvey-Langton A; Dunais B; Cohen-Codar I; Montagne N; Cua E; Fredouille-Heripret L; Laffon M; Cottalorda J; Dellamonica P; Pradier C
    HIV Med; 2015 Aug; 16(7):431-40. PubMed ID: 25981452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of HIV-associated neurocognitive disorders in the Multicenter AIDS Cohort Study.
    Sacktor N; Skolasky RL; Seaberg E; Munro C; Becker JT; Martin E; Ragin A; Levine A; Miller E
    Neurology; 2016 Jan; 86(4):334-40. PubMed ID: 26718568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low prevalence of neurocognitive impairment in early diagnosed and managed HIV-infected persons.
    Crum-Cianflone NF; Moore DJ; Letendre S; Poehlman Roediger M; Eberly L; Weintrob A; Ganesan A; Johnson E; Del Rosario R; Agan BK; Hale BR
    Neurology; 2013 Jan; 80(4):371-9. PubMed ID: 23303852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.